EarningsQ2 2024 Earnings Report

Kuros Biosciences (CSBTF) Q2 2024 Earnings Report

15 Followers

CSBTF Q2 2024 EPS Results

Actual EPS>-$0.01

Consensus EPS―

Beat/Miss―

One Year Ago EPS-$0.17

Actual Revenue$39.74M

Expected Revenue$33.57M

Beat/MissBeat by +$6.16M

YoY Revenue Growth+147.51%

QuarterQ2 2024

Date08/08/2024

TimeBefore Open

Conference CallThursday, August 8, 2024

CSBTF Upcoming Earnings

Kuros Biosciences's next earnings date is estimated for March 17, 2027, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Mar 17, 2027	2026 (Q4)	- / -	0.116	―
Aug 13, 2026	2026 (Q2)	0.07 / 0.07	-0.045	264.44% (+0.12)
Mar 10, 2026	2025 (Q4)	0.00 / 0.12	-0.137	184.55% (+0.25)
Aug 14, 2025	2025 (Q2)	- / -0.06	-0.007	-650.00% (-0.05)
Mar 11, 2025	2024 (Q4)	- / -0.14	-0.296	53.59% (+0.16)
Aug 08, 2024	2024 (Q2)	- / >-0.01	-0.172	95.65% (+0.16)
Mar 13, 2024	2023 (Q4)	- / -0.30	-0.397	25.47% (+0.10)
Aug 09, 2023	2023 (Q2)	- / -0.17	-0.141	-22.12% (-0.03)
Mar 15, 2023	2022 (Q4)	- / -0.40	-0.283	-40.09% (-0.11)
Aug 09, 2022	2022 (Q2)	- / -0.14	-0.004	-3666.67% (-0.14)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed